Viking Therapeutics is mispriced due to the successful but misunderstood clinical results of their oral GLP-1 treatment. Read ...
KUCHING: Jaya Tiasa Holdings Bhd is accelerating its oil palm replanting programme, targeting to cultivate 1,743ha for its ...
Ares Management’s fair value estimate has been adjusted slightly downward, moving from $180.20 to $180.00 per share. This modest revision follows recent research that highlights both positive and ...
After the Raiders ended the 2023 season with a 5-4 record with Antonio Peirce as the coach and Kelly the interim GM, owner ...
AM Best has affirmed the Financial Strength Rating of B and the Long-Term Issuer Credit Rating of“ bb+” of Quest Insurance Group Limited. The ratings also factor in the neutral impact from the company ...
The CCNB Amphitheatre has hosted several high profile artists ...
Sun Peak Metals Corp. (TSXV:PEAK)(OTCQB:SUNPF) ("Sun Peak" or the "Company") today announced that, further to its news ...
The market was not impressed with Global Industrial's earnings -- but I think the business may be an interesting dividend stock.
The common trainer phrase in the game is, of course, “I choose you!” as a Pokémon is sent into battle, and the idea that the ...
In an environment of persistent economic unease, banks have a unique opportunity to help small businesses, Sekou Kaalund, U.S ...
Popular marijuana brand Grön — one of many marijuana companies in New York now facing potential hardship due to its connections with Long Island-based processor Omnium Health — is pushing back on news ...
Viking Therapeutics CEO Brian Lian is watching the growth of interest in MASH and obesity but prepared to go it alone.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results